Author:
Ferrant Janine L.,Benjamin Christopher D.,Cutler Anne H.,Kalled Susan L.,Hsu Yen-Ming,Garber Ellen A.,Hess Donna M.,Shapiro Renee I.,Kenyon Norma S.,Harlan David M.,Kirk Allan D.,Burkly Linda C.,Taylor Frederick R.
Publisher
Oxford University Press (OUP)
Subject
Immunology,General Medicine,Immunology and Allergy
Reference43 articles.
1. Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E. and Noelle, R. J. 1996. Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol.14:591.
2. Burkly, L. C. 2001. CD40L pathway blockade as an approach to immunotherapy. In Monroe, D. M., Hedner, U., Hoffman, M. R., Negrier, C., Savidge, G. F. and White, G. C. I., eds., Advances in Experimental Medicine and Biology, p. 135. Kluwer Academic/Plenum Publishers, Dordrecht, The Netherlands.
3. George, J., Raskob, G., Lichtin, A. et al.1998. Safety and effect on platelet count of single-dose monoclonal antibody to CD40 ligand in patients with chronic ITP. Blood92:2906.
4. George, J., Raskob, G., Bussel, J. et al.1999. Safety and effect on platelet count of repeated doses of monoclonal antibody to CD40 ligand in patients with chronic ITP. Blood94:71.
5. Grammer, A. C., Slota, R., Fischer, R. et al.2003. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J. Clin. Investig.112:1506.
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献